1.
|
Please
tell us the average occupancy rates, expressed as a percentage, of your
income properties for each of the last five years on a portfolio
basis. Confirm that you will provide similar disclosure in
future filings.
|
Year
|
Occupancy
%
|
||
2004
|
100%
|
(1)
|
|
2005
|
100%
|
(2)
|
|
2006
|
100%
|
||
2007
|
100%
|
||
2008
|
100%
|
(1)
|
As
set forth in the Form 10-K for the year ended December 31, 2008, four CVS
Corp. (CVS), (then Eckerd) stores, consisting of a total of 50,708 square
feet, were closed during the third quarter of 2004. CVS has continued to
make current lease payments in accordance with the terms of the applicable
lease agreements.
|
(2)
|
During
2005, two of the unoccupied CVS stores, consisting of a total of
23,082
square feet, were subleased by CVS.
|
|
2.
|
In
future filings, please disclose your average effective annual rental per
square foot for the last five years. Provide the proposed
disclosure in your response.
|
Year
|
Annual Rental Per
Square
Foot
|
|
2004
|
$21.13
|
|
2005
|
$17.85
|
|
2006
|
$17.26
|
|
2007
|
$17.27
|
|
2008
|
$16.99
|
|
We
will provide similar disclosure in future
filings.
|
3.
|
Please
provide a schedule of lease expirations for each of the ten years starting
with the fiscal year to which your annual report pertains. The
schedule should include the following
information:
|
·
|
The
number of tenants whose leases will
expire;
|
·
|
The
total area in square feet covered by such
lease;
|
·
|
The
annual rental represented by such leases;
and
|
·
|
The
percentage of gross annual rental represented by such
leases.
|
|
Provide
similar disclosure in future filings and tell us how you plan to
comply.
|
4.
|
We
note your disclosure on page 9 regarding your two largest income property
tenants, CVS and Walgreens. Please identify each tenant that
occupies 10% or more of your rentable square footage or accounts for 10%
or more of your gross revenues and disclose the amounts attributed to each
as of the end of the period covered by your report. Also,
disclose the principal provisions of your leases with those
tenants. Provide similar disclosure in future filings and tell
us how you plan to comply.
|
|
CVS
Corp. -- 21% of portfolio by square feet, 28% by
Revenue
|
|
100%
of CVS Stores owned by CTO were originally leased and occupied by Eckerd
Corporation; CVS Pharmacy Inc. acquired Eckerd Corporation in August 2004
and assumed the leases
|
|
Primarily
20 yr. initial lease terms (one lease term is 25
years)
|
|
Primarily
4 option periods of 5 yrs. each
|
|
Primarily
no rent increases until option
period
|
|
Rent
ranges from $19+/- per square foot (PSF) to $27+/-
PSF
|
|
All
CVS leases are triple-net (no Landlord operating expense and maintenance
responsibility)
|
|
20
yr. or 25 yr. initial lease terms
|
|
Primarily
6 option periods of 5 yrs. each
|
|
No
rent increases until option period
|
|
Rent
ranges from $19+/- to $26+/- PSF
|
|
Walgreen
leases are either double-net (Landlord responsible for structure, roof and
in some leases the parking lot) or triple-net (no Landlord operating
expense and maintenance
responsibility)
|
|
20
yr. initial lease term
|
|
6
option periods of 5 yrs. each
|
|
No
rent increases until option period
|
|
Rent
of $6+ PSF
|
|
Double-net
(Landlord responsible for structure, roof, and parking
lot)
|
5.
|
We
note that you have experienced a decline in net income in each fiscal year
since 2005. This appears to be a material trend in your
operations. Please revise future filings to include a
discussion of this trend and the economic or other factors that have had
an adverse impact on your revenues. We note that the
year-to-year comparisons attribute decreases in profits in part to lower
profits from commercial land sales. Your overview should
discuss in more detail the factors that management believes contributed to
lower profits from commercial land sales. In your response
letter, please tell us how you will comply with this
comment.
|
|
Form
10-Q for the Period Ended September 30,
2009
|
|
Note
6. Notes Receivable, page 10
|
6.
|
Please
tell us, and disclose in future filings, the nature and extent of the
collateralization of non-accrual loans and how you measured impairment of
these loans for each period during which they were on non-accrual
status. In addition, in future filings include all disclosures
required by SFAS No. 114. Please provide us with your proposed
disclosures.
|
September
30,
|
December
31,
|
|||||||
2009
|
2008
|
|||||||
Investment
in Impaired
|
||||||||
Notes
with Allowance
|
||||||||
for
Losses
|
-- | -- | ||||||
Investment
in Impaired
|
||||||||
Notes
with No Allowance
|
||||||||
for
Losses
|
2,269,580 | 1,945,912 |
Following are average investments
in impaired loans and accrued interest income recorded on these loans for
the periods ending:
|
||||||||||||||||
Three Months
Ended
|
Nine Months
Ended
|
|||||||||||||||
September
30,
|
September
30,
|
September
30,
|
September
30,
|
|||||||||||||
2009
|
2008
|
2009
|
2008
|
|||||||||||||
Average
Investment in
|
||||||||||||||||
Impaired
Loans
|
3,242,536 | 486,478 | 3,826,309 | 194,591 | ||||||||||||
Interest
Income Recorded
|
||||||||||||||||
On
Impaired Loans While
|
||||||||||||||||
Loans
Were Impaired
|
-- | -- | -- | -- | ||||||||||||
Interest
Income Recognized
|
||||||||||||||||
Using
Cash-Basis Method
|
||||||||||||||||
of
Accounting
|
-- | -- | -- | -- | ||||||||||||
There
was no allowance for credit losses during the periods as we looked at the
fair value of the collateral supporting the notes receivable and
determined no provision was necessary.
As
a policy interest income is not accrued once the note has been determined
to be impaired, no cash receipts were received on the impaired
notes.
|
|
Similar
disclosure will be included in future
filings.
|
|
Exhibits
31.1 and 31.2
|
7.
|
We
note that you have omitted from your certifications the phrase “(the
registrant’s fourth fiscal quarter in the case of an annual report)” from
paragraph 4(d) and the phrase “(or persons performing the equivalent
functions)” from paragraph 5. Please confirm that in future
filings, you will file certifications in the exact form as outlined in
Item 601(B)(31)(i) of Regulation
S-K.
|
8.
|
We
note that Messrs. McMunn, Teeters and Apgar received cost of living and
merit increases in their base salaries for 2008 and that such merit
increases were based on the company’s and individual’s 2007
performance. Please identify and quantify the specific aspects
of company and individual performance that the Compensation Committee
considered in making these determinations. Provide us with
sample disclosure and confirm that you will provide similar disclosure as
applicable in future filings.
|
9.
|
In
future filings, with respect to long-term incentive awards, such as stock
option compensation, please provide a more detailed analysis of how the
company determined the actual awards. Please disclose the
actual factors considered in making the equity awards for each named
executive officer.
|
·
|
the
Company is responsible for the adequacy and accuracy of the disclosure in
the filing;
|
·
|
Staff
comments or changes to disclosure in response to Staff comments do not
foreclose the Commission from taking any action with respect to the
filings; and
|
·
|
the
Company may not assert Staff comments as a defense in any proceeding
initiated by the Commission or any person under the federal securities
laws of the United States.
|